18F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster? (Q42692487)

4 November 2017

0 references

18F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster? (English)

1 reference

4 November 2017

1

Otto C Boerman

1 reference

4 November 2017

Martin Gotthardt

2

1 reference

4 November 2017

1 March 2012

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

4 November 2017

1 reference

4 November 2017

39

1 reference

4 November 2017

3

1 reference

4 November 2017

461-462

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-011-2020-9

4 November 2017

0 references

cites work

18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276772

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276772

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276772

Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276772

Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276772

Glucagon-like peptide 1-receptor scans to localize occult insulinomas.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276772

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276772

GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276772

Insulin secretion in type 1 diabetes

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3276772

Residual insulin positivity and pancreatic atrophy in relation to duration of chronic Type 1 (insulin-dependent) diabetes mellitus and microangiopathy

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22170323

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22170323

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22170323

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-011-2020-9

1 reference

4 November 2017

1 reference

4 November 2017

1 reference

PMCID

3276772